Enferm Infecc Microbiol Clin
October 2012
Objective: To evaluate a new chemiluminescent microparticle immunoassay (ARCHITECT Chagas(®), Abbott).
Methods: In this study, 165 samples were tested by two different serological tests. The ARCHITECT Chagas(®) assay was performed using ARCHITECT i2000(SR) system (Abbott).